Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 2019
Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the tr...
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of t...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatme...
Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatmen...
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by patchy hair loss. ...
Supplementary figure for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatm...
Korn Triyangkulsri, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty o...
Kerry-Ann L Dillon 1, 2 1Department of Microbiology, Immunology and Pharmacology, St. George’...
Supplemental material for manuscript published in the Journal for the American Academy of Dermatolog...
Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its ma...
Alopecia areata (AA) is a common autoimmune nonscarring alopecia. AA presents heterogeneously and is...
Introduction Alopecia Areata is a nonscarring hair loss disorder and is the most common hair loss ca...
Treatment of alopecia totalis and alopecia universalis is often challenging and unsatisfactory. Rece...
Copyright © 2019 John Wiley & Sons, Inc. All rights reserved.Alopecia areata (AA) is a non-scarring ...
Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the tr...
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of t...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatme...
Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatmen...
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by patchy hair loss. ...
Supplementary figure for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatm...
Korn Triyangkulsri, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty o...
Kerry-Ann L Dillon 1, 2 1Department of Microbiology, Immunology and Pharmacology, St. George’...
Supplemental material for manuscript published in the Journal for the American Academy of Dermatolog...
Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its ma...
Alopecia areata (AA) is a common autoimmune nonscarring alopecia. AA presents heterogeneously and is...
Introduction Alopecia Areata is a nonscarring hair loss disorder and is the most common hair loss ca...
Treatment of alopecia totalis and alopecia universalis is often challenging and unsatisfactory. Rece...
Copyright © 2019 John Wiley & Sons, Inc. All rights reserved.Alopecia areata (AA) is a non-scarring ...
Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the tr...
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of t...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
DOI
Add to ORKG